4-tert-butyl-2-methylsulfanyl-pyrimidine | 66522-12-1

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 4-tert-butyl-2-methylsulfanyl-pyrimidine
• 英文别名: 4-Tert-butyl-2-(methylthio)pyrimidine；4-tert-butyl-2-methylsulfanylpyrimidine
• CAS: 66522-12-1
• 化学式: C₉H₁₄N₂S
• 分子量: 182.29
• InChiKey: HYOPLDXFQWLBPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  51.1
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
  申请人：Bursavich Matthew Gregory

  公开号：US20090325964A1

  公开（公告）日：2009-12-31

  The present teachings relate to piperazine metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators having Formula I: wherein the constituent variables are as defined herein. The present teachings further relate to methods for the preparation of the compounds, and to methods for using the compounds for treatment of diseases and disorders including schizophrenia, paranoia, depression, manic-depressive illness and anxiety.

  本发明涉及具有公式I的哌嗪代谢型谷氨酸受体5（mGluR5）负向变构调节剂： 其中，组成变量如本文所定义。本发明还涉及制备该化合物的方法，并涉及使用该化合物治疗疾病和障碍的方法，包括精神分裂症、偏执症、抑郁症、躁郁病和焦虑症。
• PROCESS FOR PRODUCTION OF 4-ACETYLPYRIMIDINES AND CRYSTALS THEREOF
  申请人：Takahashi Daisuke

  公开号：US20080015353A1

  公开（公告）日：2008-01-17

  Compound (II) is reacted with formate in the presence of an alkali metal alkoxide and the like to give compound (III); then this is reacted with compound (IVa) or compound (IVb) to give compound (V); then this is reacted with compound (VI) to give compound (VII); and then this is deprotected to give compound (I). The present invention provides an industrially advantageous production method of a 4-acetylpyrimidine compound useful as a synthetic intermediate for a pharmaceutical product: wherein X is a methylthio group and the like, R 1 is a lower alkyl group and the like, R 2 is a lower alkyl group optionally having substituent(s) and the like, M is an alkali metal and X 1 is a halogen atom.

  化合物(II)在碱金属烷氧化物等存在下与甲酸酯反应，得到化合物(III)；然后将其与化合物(IVa)或化合物(IVb)反应，得到化合物(V)；然后将其与化合物(VI)反应，得到化合物(VII)；最后去保护得到化合物(I)。本发明提供了一种工业上有利的生产方法，用于制备一种4-乙酰基嘧啶化合物，该化合物可用作制药产品的合成中间体：其中X是甲硫基等，R1是低碳基等，R2是可选地具有取代基的低碳基等，M是碱金属，X1是卤素原子。
• Amine Derivatives as Potassium Channel Blockers
  申请人：Harvey Andrew

  公开号：US20140336198A1

  公开（公告）日：2014-11-13

  The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.

  本发明涉及用于调节细胞中钾通道活性的化合物，特别是用于调节T细胞中发现的Kv1.3通道活性的化合物。本发明还涉及使用这些化合物治疗或预防自身免疫和炎症性疾病，包括多发性硬化症，含有这些化合物的制药组合物以及它们的制备方法。
• TROPANE DERIVATIVES USEFUL AS PESTICIDES
  申请人：Selles Patrice

  公开号：US20100331348A1

  公开（公告）日：2010-12-30

  Compounds of formula (I) wherein the substituents have the meanings assigned to them in claim 1, are useful as pesticides.

  式(I)中的化合物，其中取代基具有在权利要求书1中分配给它们的含义，可用作杀虫剂。
• HETEROCYCLIC G-PROTEIN-COUPLED RECEPTOR 52 (GPR52) AGONISTS
  申请人：Board of Regents, The University of Texas System

  公开号：US20220112164A1

  公开（公告）日：2022-04-14

  Embodiments are directed to novel GPR52 activators. In particular, a series of novel 1-(pyrimidin-4-yl)indoline-4-carboxamide analogs that have been identified as potent and selective GPR52 agonists. The optimized GPR52 agonist that, for example, can be used as a valuable pharmacological tool or a drug candidate for investigating the physiological and therapeutic potential of GPR52 activation for various human diseases.

  本发明涉及新型GPR52激动剂。具体而言，已经确定了一系列新型1-(嘧啶-4-基)吲哚-4-甲酰胺类似物，这些类似物被识别为有效且选择性的GPR52激动剂。优化的GPR52激动剂例如可以用作有价值的药理学工具或药物候选物，用于研究GPR52激活在各种人类疾病的生理和治疗潜力。